A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity
Shuwei Liang,
Eric Tran,
Xin Du,
Jiajun Dong,
Harrison Sudholz,
Hao Chen,
Zihan Qu,
Nicholas D. Huntington,
Jeffrey J. Babon,
Nadia J. Kershaw,
Zhong-Yin Zhang,
Jonathan B. Baell,
Florian Wiede () and
Tony Tiganis ()
Additional contact information
Shuwei Liang: Monash University
Eric Tran: Monash University
Xin Du: Monash University
Jiajun Dong: Purdue University
Harrison Sudholz: Monash University
Hao Chen: Walter and Eliza Hall Institute of Medical Research
Zihan Qu: Purdue University
Nicholas D. Huntington: Monash University
Jeffrey J. Babon: Walter and Eliza Hall Institute of Medical Research
Nadia J. Kershaw: Walter and Eliza Hall Institute of Medical Research
Zhong-Yin Zhang: Purdue University
Jonathan B. Baell: Monash University
Florian Wiede: Monash University
Tony Tiganis: Monash University
Nature Communications, 2023, vol. 14, issue 1, 1-27
Abstract:
Abstract The inhibition of protein tyrosine phosphatases 1B (PTP1B) and N2 (PTPN2) has emerged as an exciting approach for bolstering T cell anti-tumor immunity. ABBV-CLS-484 is a PTP1B/PTPN2 inhibitor in clinical trials for solid tumors. Here we have explored the therapeutic potential of a related small-molecule-inhibitor, Compound-182. We demonstrate that Compound-182 is a highly potent and selective active site competitive inhibitor of PTP1B and PTPN2 that enhances T cell recruitment and activation and represses the growth of tumors in mice, without promoting overt immune-related toxicities. The enhanced anti-tumor immunity in immunogenic tumors can be ascribed to the inhibition of PTP1B/PTPN2 in T cells, whereas in cold tumors, Compound-182 elicited direct effects on both tumor cells and T cells. Importantly, treatment with Compound-182 rendered otherwise resistant tumors sensitive to α-PD-1 therapy. Our findings establish the potential for small molecule inhibitors of PTP1B and PTPN2 to enhance anti-tumor immunity and combat cancer.
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/s41467-023-40170-8 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40170-8
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-023-40170-8
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().